In this review, we discuss the molecular structure and regulation of PTEN, the mechanisms leading to its dysregulation in various cancers, and therapeutic approaches that target this critical pathway, particularly those focused on restoring or enhancing PTEN function in tumors, whether by exporting vesicles out of a cell or by finding ways to repair genetic defects via CRISPR technology. This evidence concerns the gene PTEN and cancer.